Reports for TEVA-NARATRIPTAN
Brand name
TEVA-NARATRIPTAN
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02314304 |
Ingredients
NARATRIPTAN |
Ingredient Strength
2.5 MG |
ATC Code
N02CC |
ATC Descriptor
ANTIMIGRAINE PREPARATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-NARATRIPTAN | 8 | Resolved | 2017-03-13 | 2018-03-14 | 1137 |
| TEVA-NARATRIPTAN | P/P 8's | Resolved | 2020-07-23 | 2020-09-17 | 120884 |
| TEVA-NARATRIPTAN | PP 8 | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
| TEVA-NARATRIPTAN | 8 | Resolved | 2022-04-08 | 2022-06-17 | 158428 |
| TEVA-NARATRIPTAN | PP 8 | Resolved | 2022-04-21 | 2022-06-03 | 159204 |
| TEVA-NARATRIPTAN | 8 | Resolved | 2022-09-07 | 2022-10-01 | 168737 |
| TEVA-NARATRIPTAN | PP 8 | Resolved | 2023-02-09 | 2023-02-16 | 184207 |
| TEVA-NARATRIPTAN | 8 | Resolved | 2023-06-08 | 2023-08-18 | 194131 |
| TEVA-NARATRIPTAN | 8 | Resolved | 2023-06-19 | 2023-07-06 | 195487 |
Showing 1 to 9 of 9
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0